Vanguard Group’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-196,217
| Closed | -$1.31M | – | 4420 |
|
|
2025
Q3 | $1.31M | Sell |
196,217
-500
| -0.3% | -$3.37K | ﹤0.01% | 3708 |
|
|
2025
Q2 | $1.36M | Buy |
196,717
+29,197
| +17% | +$196K | ﹤0.01% | 3660 |
|
|
2025
Q1 | $1.13M | Sell |
167,520
-257
| -0.2% | -$1.8K | ﹤0.01% | 3674 |
|
|
2024
Q4 | $1.24M | Hold |
167,777
| – | – | ﹤0.01% | 3694 |
|
|
2024
Q3 | $876K | Sell |
167,777
-1
| -0% | -$5 | ﹤0.01% | 3815 |
|
|
2024
Q2 | $913K | Hold |
167,778
| – | – | ﹤0.01% | 3814 |
|
|
2024
Q1 | $1.09M | Buy |
167,778
+9,898
| +6% | +$88.3K | ﹤0.01% | 3788 |
|
|
2023
Q4 | $1.2M | Buy |
157,880
+18,300
| +13% | +$123K | ﹤0.01% | 3771 |
|
|
2023
Q3 | $833K | Sell |
139,580
-2
| -0% | -$21 | ﹤0.01% | 3900 |
|
|
2023
Q2 | $1.71M | Sell |
139,582
-6,645
| -5% | -$87.9K | ﹤0.01% | 3718 |
|
|
2023
Q1 | $2.58M | Buy |
146,227
+377
| +0.3% | +$19.4K | ﹤0.01% | 3584 |
|
|
2022
Q4 | $7.58M | Buy |
145,850
+534
| +0.4% | +$38.8K | ﹤0.01% | 3084 |
|
|
2022
Q3 | $12.2M | Buy |
145,316
+49,481
| +52% | +$6.57M | ﹤0.01% | 2854 |
|
|
2022
Q2 | $14M | Sell |
95,835
-6,038
| -6% | -$879K | ﹤0.01% | 2817 |
|
|
2022
Q1 | $15.7M | Buy |
101,873
+91,565
| +888% | +$20.3M | ﹤0.01% | 2909 |
|
|
2021
Q4 | $2.84M | Buy |
10,308
+149
| +1% | +$68.8K | ﹤0.01% | 3902 |
|
|
2021
Q3 | $6.63M | Buy |
10,159
+2,659
| +35% | +$2.34M | ﹤0.01% | 3486 |
|
|
2021
Q2 | $10.3M | Buy |
+7,500
| New | +$10.3M | ﹤0.01% | 3184 |
|
Vanguard Group's NEUE Position: Q4 2025 in Review
Vanguard Group sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 196,217 shares — an estimated $1.31M sold.
Vanguard Group first reported a position in NEUE in Q2 2021 and held it in 18 quarters. The position peaked at $15.7M in Q1 2022. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.
- Vanguard Group reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
- Vanguard Group sold 196,217 NeueHealth shares in Q4 2025, an estimated $1.31M.
- Vanguard Group first reported a position in NeueHealth in Q2 2021 and held it in 18 quarters.
- Vanguard Group's NeueHealth position peaked at $15.7M in Q1 2022.
- 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.